These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22938530)

  • 21. Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: a case report.
    Hultgren TL; Srinivasan SK; DiMaio DJ
    Cutis; 2007 Apr; 79(4):307-11. PubMed ID: 17500379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis.
    Favre M; Orth G; Majewski S; Baloul S; Pura A; Jablonska S
    J Invest Dermatol; 1998 Apr; 110(4):311-7. PubMed ID: 9540967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus.
    Holmes C; Chong AH; Tabrizi SN; Downes N; Nindl I
    Australas J Dermatol; 2009 Feb; 50(1):44-7. PubMed ID: 19178492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures.
    Boxman IL; Mulder LH; Noya F; de Waard V; Gibbs S; Broker TR; ten Kate F; Chow LT; ter Schegget J
    J Invest Dermatol; 2001 Dec; 117(6):1397-404. PubMed ID: 11886500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired epidermodysplasia verruciformis in a child with the human immunodeficiency virus.
    Cowan KR; Gonzalez Santiago TM; Tollefson MM
    Pediatr Dermatol; 2013; 30(6):e252-4. PubMed ID: 23758597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease.
    Berger TG; Sawchuk WS; Leonardi C; Langenberg A; Tappero J; Leboit PE
    Br J Dermatol; 1991 Jan; 124(1):79-83. PubMed ID: 1847068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired epidermodysplasia verruciformis in a renal transplant recipient--case report.
    Mendes AD; Bittencourt Mde J; Moure ER; D'Macêdo CM; Yamaki IN; Araújo DM
    An Bras Dermatol; 2014; 89(1):144-6. PubMed ID: 24626660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cimetidine therapy for epidermodysplasia verruciformis.
    Micali G; Nasca MR; Dall'Oglio F; Musumeci ML
    J Am Acad Dermatol; 2003 Feb; 48(2 Suppl):S9-10. PubMed ID: 12582373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermodysplasia verruciformis in two half brothers with HIV infection.
    Hu W; Nuovo G; Willen M; Somach S
    J Cutan Med Surg; 2004; 8(5):357-60. PubMed ID: 15868315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    Moore S; Rady P; Tyring S
    Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant.
    Henning A; Weaver J; Reedy M
    Am J Dermatopathol; 2021 Jan; 43(1):71-74. PubMed ID: 32568838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.
    Castro-Perez GA; Sorin I; Bravo AI; Mazzuoccolo LD
    Actas Dermosifiliogr; 2013 Oct; 104(8):731-3. PubMed ID: 24067256
    [No Abstract]   [Full Text] [Related]  

  • 34. [Low-dose prophylactic oral isotretinoin treatment for 18 years in a patient with epidermodysplasia verruciformis and numerous squamous cell carcinomas].
    Troyanova-Slavkova S; Eickenscheidt L; Pönnighaus JM; Kowalzick L
    Hautarzt; 2018 Dec; 69(12):1033-1038. PubMed ID: 30250966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Imiquimod for the topical treatment of focal epithelial hyperplasia (Heck disease) in a child].
    Maschke J; Brauns TC; Goos M
    J Dtsch Dermatol Ges; 2004 Oct; 2(10):848-50. PubMed ID: 16281588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis.
    Vu J; Wallace GR; Singh R; Diwan H; Prieto V; Rady P; Tyring S; Duvic M
    Am J Clin Dermatol; 2007; 8(5):307-10. PubMed ID: 17902733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients.
    Rallis E; Paparizos V; Kyriakis K; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):195-6. PubMed ID: 18462300
    [No Abstract]   [Full Text] [Related]  

  • 38. Epidermodysplasia Verruciformis-like HPV Infection of the Vulva in Immunosuppressed Women.
    Pohthipornthawat N; Feldman S; Granter SR; Laga AC; Crum CP; Herfs M
    Int J Gynecol Pathol; 2018 May; 37(3):233-238. PubMed ID: 28700430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic low-dose isotretinoin maintains remission status in epidermodysplasia verruciformis.
    Rallis E; Papatheodorou G; Bimpakis E; Butanska D; Menounos P; Papadakis P
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):523-5. PubMed ID: 18363932
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin.
    Iraji F; Faghihi G
    Clin Exp Dermatol; 2000 Jan; 25(1):41-3. PubMed ID: 10671971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.